Cost of Hepatitis C Treatment in the Correctional Setting

Journal of Correctional Health Care

Volumn 11, Issue 2, 2005, Pages 199-212

  Paris, Joseph ^a   Pradhan, Monica M ^b   Allen, Scott ^c   Cassidy, William M ^b  

^a Georgia Department of Corrections   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^c RHODE ISLAND DEPARTMENT OF CORRECTIONS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84998085828     PISSN: 10783458     EISSN: None     Source Type: Journal    
DOI: 10.1177/107834580401100207     Document Type: Article

References (17)

1. Allen, S. A. (2003). Developing a systematic approach to hepatitis C for correctional systems: Controversies and emerging consensus. HEPP Report, 3, 1-4. Retrieved Nov. 25, 2003, from http://www.hivcorrections.org/archives/april03/mainarticle.html
2. Allen, S. A., Spaulding, A. C., Osei, A. M., Taylor, L. E., Cabral, A. M., & Rich, J. D. (2003). Treatment of chronic hepatitis C in a state correctional facility. Annals of Internal Medicine, 138(3), 187-190.
3. Cassidy, W. M. (2003). Treating hepatitis C in prisons. Paper presented at the Management of Hepatitis C in Prisons meeting, San Antonio, TX.
4. Davis, G. L., Wong, J. B., McHutchison, J. G., Manns, M. P., Harvey, J., & Albrecht, J. (2003). Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C. Hepatology, 38(3), 645-652.
5. Drugstore.com. (n.d.) Drug prices & information. Retrieved Feb. 4, 2004, from http://www.drugstore.com/pharmacy/drugindex
6. Federal Bureau of Prisons. (2003). Clinical practice guidelines for the prevention and treatment of viral hepatitis. Retrieved Feb. 24, 2004, from http://www.nicic.org/pubs/2003/016972.pdf
7. Fried, M. W., Shiffman, M. L., Reddy, K. R., Smith, C., Marinos, G., Goncales, F. L., Jr., et al. (2002). Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. New England Journal of Medicine, 347(13), 975-982.
8. Ghany, M. G., Kleiner, D. E., Alter, H., Doo, E., Khokar, F., Promrat, K., et al. (2003). Progression of fibrosis in chronic hepatitis C. Gastroenterology, 124(1), 97-104.
9. Jeffers, L. J., Cassidy, W., Howell, C. D., Hu, S., & Reddy, K. R. (2004). Peginterferon alfa-2a (40 kd) and ribavirin for black American patients with chronic HCV genotype 1. Hepatology, 39(6), 1702-1708.
10. Leigh, J. P., Bowlus, C. L., Leistikow, B. N., & Schenker, M. (2001). Costs of hepatitis C. Archives of Internal Medicine, 161(18), 2231-2237.
11. Manns, M. P., McHutchison, J. G., Gordon, S. C., Rustgi, V. K., Shiffman, M., Reindollar, R., et al. (2001). Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: A randomised trial. Lancet, 358(9286), 958-965.
12. Marcellin, P., Boyer, N., Gervais, A., Martinot, M., Pouteau, M., Castelnau, C., et al. (1997). Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy. Annals of Internal Medicine, 127(10), 875-881.
13. National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C: 2002-June 10-12, 2002. (2002). Hepatology, 36(5 Suppl. 1), S3-20.
14. Pfister, J., & Hurie, M. (2000). Targeted hepatitis C virus (HCV) screening of inmates upon admission to the Wisconsin adult correctional system. Paper presented at the International Conference on Emerging Infectious Diseases, Atlanta, GA.
15. Taylor, Z., & Nguyen, C. (2002). Cost-effectiveness of preventing tuberculosis in prison populations. In The health status of soon-to-be-released inmates: A report to Congress: Vol. 2 (pp. 109-124). Chicago: National Commission on Correctional Health Care.
16. Varghese, B., & Peterman T. A. (2002). Cost effectiveness of HIV-testing and counseling in U.S. prisons. In The health status of soon-to-be-released inmates: A report to Congress: Vol. 2 (pp. 125-134). Chicago: National Commission on Correctional Health Care.
17. Weinbaum, C., Lyerla, R., & Margolis, H. S. (2003). Prevention and control of infections with hepatitis viruses in correctional settings. Morbidity and Mortality Weekly Report Recommendations and Reports, 52(RR-1), 1-36; quiz CE31-34.